Variable Vaccine Efficacy & Delta's Investment Effect

In this week's broadcast featuring Bloomberg Intelligence analysts and their research, Sam Fazeli examines why the efficacy of Pfizer-BioNTech's vaccine varies wildly from Israel to the U.K. and Gina Martin Adams discusses how surging delta-variant cases could change investment strategies. Damian Sassower sheds light on the role emerging markets will play on global equities, Mike McGlone addresses the question of whether commodities have peaked, and Ira Jersey breaks down the Fed's FOMC meeting.Hosts: Alix Steel and Paul Sweeney. Producer: Tim HerroThe BI Radio show podcasts through Apple’s iTunes, Spotify and Luminary. It broadcasts on Saturdays and Sundays at noon on Bloomberg’s flagship station WBBR (1130 AM) in New York, 106.1 FM/1330 AM in Boston, 99.1 FM in Washington, 960 AM in the San Francisco area, channel 119 on SiriusXM, www.bloombergradio.com, and iPhone and Android mobile apps.Bloomberg Intelligence, the research arm of Bloomberg L.P., provides in-depth analysis and data on more than 2,000 companies and 130 industries. On the Bloomberg terminal, run BI <GO>.See omnystudio.com/listener for privacy information.